Indian J Pharm Close
 

Figure 4: Bone calcium content changes. OVX caused signifi cant bone calcium decrease. After 12 weeks’ treatment with genistein, bone calcium was 96.3, 99.3 and 99.0% of SH group. The effect of genistein at middle (9 mg/kg) and high (18 mg/kg) doses on bone calcium was especially signifi cant (P < 0.05 vs low dose group). Data is expressed as the mean ± SE. *P < 0.05,**P < 0.01 vs OVX. #P < 0.05 vs M, H groups. L: low dose (4.5 mg/kg), M: mid-dose (9 mg/kg), H: high dose (18 mg/kg).

Figure 4: Bone calcium content changes. OVX caused signifi cant
bone calcium decrease. After 12 weeks’ treatment with genistein, bone
calcium was 96.3, 99.3 and 99.0% of SH group. The effect of genistein
at middle (9 mg/kg) and high (18 mg/kg) doses on bone calcium was
especially signifi cant (P < 0.05 vs low dose group). Data is expressed
as the mean ± SE. *P < 0.05,**P < 0.01 vs OVX. #P < 0.05 vs M, H
groups. L: low dose (4.5 mg/kg), M: mid-dose (9 mg/kg), H: high dose
(18 mg/kg).